Levi Strauss & Co (LEVI) concluded trading on Thursday at a closing price of $19.73, with 8.24 million shares of worth about $162.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.59% during that period and on July 10, 2025 the price saw a gain of about 1.70%. Currently the company’s common shares owned by public are about 104.59M shares, out of which, 94.64M shares are available for trading.
Stock saw a price change of 2.60% in past 5 days and over the past one month there was a price change of 12.61%. Year-to-date (YTD), LEVI shares are showing a performance of 4.06% which increased to 14.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $12.17 but also hit the highest price of $21.95 during that period. The average intraday trading volume for Levi Strauss & Co shares is 2.32 million. The stock is currently trading 7.61% above its 20-day simple moving average (SMA20), while that difference is up 11.75% for SMA50 and it goes to 13.04% higher than SMA200.
Levi Strauss & Co (NYSE: LEVI) currently have 104.59M outstanding shares and institutions hold larger chunk of about 21.83% of that.
The stock has a current market capitalization of $7.80B and its 3Y-monthly beta is at 1.21. PE ratio of stock for trailing 12 months is 22.19, while it has posted earnings per share of $0.89 in the same period. Its PEG reads 3.23 and has Quick Ratio of 0.89 while making debt-to-equity ratio of 1.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LEVI, volatility over the week remained 2.63% while standing at 2.69% over the month.
Stock’s fiscal year EPS is expected to rise by 0.58% while it is estimated to increase by 10.60% in next year. EPS is likely to grow at an annualized rate of 6.87% for next 5-years, compared to annual growth of -11.54% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on April 30, 2025 offering an Overweight rating for the stock and assigned a target price of $20 to it. On April 08, 2025, JP Morgan Upgrade their recommendations, while on April 08, 2025, Telsey Advisory Group Reiterated their ratings for the stock with a price target of $19. Stock get an Overweight rating from Barclays on January 08, 2025.
